These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21569199)

  • 41. Radiotherapy of malignant nasal tumors in 21 dogs.
    Thrall DE; Harvey CE
    J Am Vet Med Assoc; 1983 Sep; 183(6):663-6. PubMed ID: 6629976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nasal and paranasal adenocarcinomas with neuroendocrine differentiation in dogs.
    Ninomiya F; Suzuki S; Tanaka H; Hayashi S; Ozaki K; Narama I
    Vet Pathol; 2008 Mar; 45(2):181-7. PubMed ID: 18424830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of cyclooxygenase-2 in neoplasms of the mammary gland in bitches.
    Badowska-Kozakiewicz AM; Malicka E
    Pol J Vet Sci; 2010; 13(2):337-42. PubMed ID: 20731190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiotherapy of malignant nasal tumors in 67 dogs.
    Adams WM; Withrow SJ; Walshaw R; Turrell JM; Evans SM; Walker MA; Kurzman ID
    J Am Vet Med Assoc; 1987 Aug; 191(3):311-5. PubMed ID: 3654292
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistochemical expression of the cyclooxygenase-2 (COX-2) in gastric cancer. The correlations with the tumor angiogenesis and patients' survival.
    Lazăr D; Tăban S; Ardeleanu C; Simionescu C; Sporea I; Cornianu M; Vernic C
    Rom J Morphol Embryol; 2008; 49(3):371-9. PubMed ID: 18758643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. External-beam Co-60 radiotherapy for canine nasal tumors: a comparison of survival by treatment protocol.
    Yoon JH; Feeney DA; Jessen CR; Walter PA
    Res Vet Sci; 2008 Feb; 84(1):140-9. PubMed ID: 17950765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of epidermal growth factor receptor and vascular endothelial growth factor in malignant canine epithelial nasal tumours.
    Shiomitsu K; Johnson CL; Malarkey DE; Pruitt AF; Thrall DE
    Vet Comp Oncol; 2009 Jun; 7(2):106-14. PubMed ID: 19453364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of prognostic factors for dogs with primary lung tumors: 67 cases (1985-1992).
    McNiel EA; Ogilvie GK; Powers BE; Hutchison JM; Salman MD; Withrow SJ
    J Am Vet Med Assoc; 1997 Dec; 211(11):1422-7. PubMed ID: 9394893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic molecular markers.
    Millanta F; Citi S; Della Santa D; Porciani M; Poli A
    Breast Cancer Res Treat; 2006 Jul; 98(1):115-20. PubMed ID: 16538539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of radiotherapy for the treatment of intranasal tumors in cats: six cases (1980-1985).
    Straw RC; Withrow SJ; Gillette EL; McChesney AE
    J Am Vet Med Assoc; 1986 Oct; 189(8):927-9. PubMed ID: 3533873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix.
    Loncaster JA; Cooper RA; Logue JP; Davidson SE; Hunter RD; West CM
    Br J Cancer; 2000 Sep; 83(5):620-5. PubMed ID: 10944602
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prognostic significance of cyclooxygenase (COX-1 and COX-2) expression in endometrial carcinoma (clinical and immunohistochemical study)].
    Boldarian NA; Pozharisskiĭ KM; Vinokurov VL; Ten VP; Samsonova EA
    Vopr Onkol; 2008; 54(1):40-6. PubMed ID: 18416056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer.
    Queiroga FL; Pires I; Parente M; Gregório H; Lopes CS
    Vet J; 2011 Jul; 189(1):77-82. PubMed ID: 20675158
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclooxygenase-2 (COX-2) expression in canine intracranial meningiomas.
    Rossmeisl JH; Robertson JL; Zimmerman KL; Higgins MA; Geiger DA
    Vet Comp Oncol; 2009 Sep; 7(3):173-80. PubMed ID: 19691646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prognostic factors of 60 nasal cavity carcinoma patients].
    Hu W; Xie F; Chen D; Chen M; He D; Mao Z; Pan G
    Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):592-4. PubMed ID: 12667333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of COX-2 is increased with age in papillary thyroid cancer.
    Siironen P; Ristimäki A; Nordling S; Louhimo J; Haapiainen R; Haglund C
    Histopathology; 2004 May; 44(5):490-7. PubMed ID: 15139997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer.
    Juuti A; Louhimo J; Nordling S; Ristimäki A; Haglund C
    J Clin Pathol; 2006 Apr; 59(4):382-6. PubMed ID: 16467169
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of cobalt-60 radiation therapy for the treatment of nasal cavity nonkeratinizing squamous cell carcinoma in the dog.
    Correa SS; Mauldin GN; Mauldin GE; Patnaik AK
    J Am Anim Hosp Assoc; 2003; 39(1):86-9. PubMed ID: 12549620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcome of definitive fractionated radiation followed by exenteration of the nasal cavity in dogs with sinonasal neoplasia: 16 cases.
    Bowles K; DeSandre-Robinson D; Kubicek L; Lurie D; Milner R; Boston SE
    Vet Comp Oncol; 2016 Dec; 14(4):350-360. PubMed ID: 25178539
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma.
    Li JF; Chu YW; Wang GM; Zhu TY; Rong RM; Hou J; Xu M
    BJU Int; 2009 Feb; 103(3):399-405. PubMed ID: 19021626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.